Rank | Gene Set | Z-score |
---|---|---|
1 | fatty acid elongation (GO:0030497) | 8.70795487 |
2 | * ensheathment of neurons (GO:0007272) | 6.90173368 |
3 | * axon ensheathment (GO:0008366) | 6.90173368 |
4 | * myelination (GO:0042552) | 6.81476165 |
5 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.41746003 |
6 | cholesterol biosynthetic process (GO:0006695) | 5.97762130 |
7 | myelin maintenance (GO:0043217) | 5.24482228 |
8 | sterol biosynthetic process (GO:0016126) | 5.24024821 |
9 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.04560348 |
10 | phosphate ion transmembrane transport (GO:0035435) | 4.96977625 |
11 | urate metabolic process (GO:0046415) | 4.94265634 |
12 | regulation of cholesterol esterification (GO:0010872) | 4.89240743 |
13 | high-density lipoprotein particle remodeling (GO:0034375) | 4.87667377 |
14 | negative regulation of neurotransmitter transport (GO:0051589) | 4.65977081 |
15 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.62785207 |
16 | phospholipid efflux (GO:0033700) | 4.58562050 |
17 | isoprenoid biosynthetic process (GO:0008299) | 4.56315245 |
18 | oligodendrocyte differentiation (GO:0048709) | 4.52886067 |
19 | creatine metabolic process (GO:0006600) | 4.49266052 |
20 | reverse cholesterol transport (GO:0043691) | 4.46646571 |
21 | phosphate ion transport (GO:0006817) | 4.45958055 |
22 | negative regulation of cholesterol transport (GO:0032375) | 4.44074841 |
23 | negative regulation of sterol transport (GO:0032372) | 4.44074841 |
24 | response to methylmercury (GO:0051597) | 4.43823110 |
25 | regulation of collateral sprouting (GO:0048670) | 4.39159632 |
26 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.36360412 |
27 | proline metabolic process (GO:0006560) | 4.34825264 |
28 | glycerophospholipid catabolic process (GO:0046475) | 4.33910539 |
29 | negative regulation of protein localization to cell surface (GO:2000009) | 4.30705091 |
30 | amyloid precursor protein metabolic process (GO:0042982) | 4.22095392 |
31 | establishment of mitochondrion localization (GO:0051654) | 4.18372896 |
32 | apical protein localization (GO:0045176) | 4.18086537 |
33 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.17160922 |
34 | artery smooth muscle contraction (GO:0014824) | 4.15087629 |
35 | photoreceptor cell differentiation (GO:0046530) | 4.14761105 |
36 | eye photoreceptor cell differentiation (GO:0001754) | 4.14761105 |
37 | substantia nigra development (GO:0021762) | 4.08250865 |
38 | asymmetric protein localization (GO:0008105) | 4.07534076 |
39 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.06263831 |
40 | 4-hydroxyproline metabolic process (GO:0019471) | 4.03697358 |
41 | drug transmembrane transport (GO:0006855) | 4.03003265 |
42 | response to redox state (GO:0051775) | 3.98533525 |
43 | adhesion of symbiont to host cell (GO:0044650) | 3.91967130 |
44 | virion attachment to host cell (GO:0019062) | 3.91967130 |
45 | plasma lipoprotein particle assembly (GO:0034377) | 3.87220972 |
46 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.85469420 |
47 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.83744452 |
48 | cholesterol efflux (GO:0033344) | 3.83521873 |
49 | astrocyte development (GO:0014002) | 3.82974563 |
50 | glyoxylate metabolic process (GO:0046487) | 3.82726163 |
51 | plasma lipoprotein particle remodeling (GO:0034369) | 3.82512842 |
52 | protein-lipid complex remodeling (GO:0034368) | 3.82512842 |
53 | macromolecular complex remodeling (GO:0034367) | 3.82512842 |
54 | response to lipoprotein particle (GO:0055094) | 3.80108867 |
55 | L-amino acid import (GO:0043092) | 3.77028564 |
56 | myelination in peripheral nervous system (GO:0022011) | 3.73354374 |
57 | peripheral nervous system axon ensheathment (GO:0032292) | 3.73354374 |
58 | presynaptic membrane organization (GO:0097090) | 3.72394958 |
59 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.69813740 |
60 | very long-chain fatty acid metabolic process (GO:0000038) | 3.68116620 |
61 | intestinal cholesterol absorption (GO:0030299) | 3.67930119 |
62 | protein-lipid complex assembly (GO:0065005) | 3.67676982 |
63 | tonic smooth muscle contraction (GO:0014820) | 3.67130370 |
64 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.66236491 |
65 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.61062370 |
66 | regulation of bile acid biosynthetic process (GO:0070857) | 3.55985770 |
67 | presynaptic membrane assembly (GO:0097105) | 3.55803881 |
68 | L-phenylalanine metabolic process (GO:0006558) | 3.54782909 |
69 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.54782909 |
70 | cellular glucuronidation (GO:0052695) | 3.52749232 |
71 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.51929319 |
72 | drug transport (GO:0015893) | 3.48376666 |
73 | import into cell (GO:0098657) | 3.45418284 |
74 | protein palmitoylation (GO:0018345) | 3.45287025 |
75 | glucuronate metabolic process (GO:0019585) | 3.42528884 |
76 | uronic acid metabolic process (GO:0006063) | 3.42528884 |
77 | flavonoid metabolic process (GO:0009812) | 3.41365952 |
78 | nephron tubule formation (GO:0072079) | 3.37487786 |
79 | regulation of lipoprotein metabolic process (GO:0050746) | 3.37438488 |
80 | nucleotide transmembrane transport (GO:1901679) | 3.34654140 |
81 | acyl-CoA biosynthetic process (GO:0071616) | 3.31496574 |
82 | thioester biosynthetic process (GO:0035384) | 3.31496574 |
83 | magnesium ion transport (GO:0015693) | 3.29155499 |
84 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.27155432 |
85 | serine family amino acid biosynthetic process (GO:0009070) | 3.23488471 |
86 | amyloid precursor protein catabolic process (GO:0042987) | 3.22876325 |
87 | GPI anchor biosynthetic process (GO:0006506) | 3.21403515 |
88 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.18880684 |
89 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.18880684 |
90 | endocrine process (GO:0050886) | 3.18880684 |
91 | toxin transport (GO:1901998) | 3.17377782 |
92 | membrane tubulation (GO:0097320) | 3.17311430 |
93 | plasma lipoprotein particle clearance (GO:0034381) | 3.16542336 |
94 | angiotensin maturation (GO:0002003) | 3.15738917 |
95 | regulation of triglyceride catabolic process (GO:0010896) | 3.14948775 |
96 | axon development (GO:0061564) | 3.12083194 |
97 | GPI anchor metabolic process (GO:0006505) | 3.11782664 |
98 | aldehyde catabolic process (GO:0046185) | 3.09212399 |
99 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.08714919 |
100 | proline biosynthetic process (GO:0006561) | 3.06268435 |
101 | negative regulation of axonogenesis (GO:0050771) | 3.03604340 |
102 | intestinal absorption (GO:0050892) | 3.01638183 |
103 | cysteine metabolic process (GO:0006534) | 3.01554912 |
104 | plasma lipoprotein particle organization (GO:0071827) | 2.98429367 |
105 | L-ascorbic acid metabolic process (GO:0019852) | 2.97621120 |
106 | protein carboxylation (GO:0018214) | 2.97009211 |
107 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.97009211 |
108 | glutamate metabolic process (GO:0006536) | 2.93755451 |
109 | limb bud formation (GO:0060174) | 2.93397925 |
110 | protein-lipid complex subunit organization (GO:0071825) | 2.93150319 |
111 | negative regulation of lipase activity (GO:0060192) | 2.92900489 |
112 | peripheral nervous system development (GO:0007422) | 2.92872237 |
113 | cellular response to epinephrine stimulus (GO:0071872) | 2.90811752 |
114 | lipoprotein metabolic process (GO:0042157) | 2.88448935 |
115 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.88000112 |
116 | regulation of extracellular matrix disassembly (GO:0010715) | 2.87935802 |
117 | adhesion of symbiont to host (GO:0044406) | 2.86827275 |
118 | negative regulation of metanephros development (GO:0072217) | 2.86786987 |
119 | amino acid import (GO:0043090) | 2.85555035 |
120 | acylglycerol homeostasis (GO:0055090) | 2.85419626 |
121 | triglyceride homeostasis (GO:0070328) | 2.85419626 |
122 | peptidyl-cysteine modification (GO:0018198) | 2.83207016 |
123 | cellular modified amino acid catabolic process (GO:0042219) | 2.83191764 |
124 | neuron cell-cell adhesion (GO:0007158) | 2.83176125 |
125 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.79584659 |
126 | cell-cell junction maintenance (GO:0045217) | 2.77724901 |
127 | adult walking behavior (GO:0007628) | 2.77404300 |
128 | neural nucleus development (GO:0048857) | 2.76483878 |
129 | diacylglycerol metabolic process (GO:0046339) | 2.75102156 |
130 | transmission of nerve impulse (GO:0019226) | 2.74744040 |
131 | drug metabolic process (GO:0017144) | 2.74532015 |
132 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.73595098 |
133 | response to hepatocyte growth factor (GO:0035728) | 2.73172225 |
134 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.73172225 |
135 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.72885457 |
136 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.72869127 |
137 | glutathione biosynthetic process (GO:0006750) | 2.72352631 |
138 | neuronal action potential propagation (GO:0019227) | 2.71111627 |
139 | lung epithelium development (GO:0060428) | 2.71053201 |
140 | glucose 6-phosphate metabolic process (GO:0051156) | 2.71021242 |
141 | metanephric tubule development (GO:0072170) | 2.70631009 |
142 | metanephric nephron tubule development (GO:0072234) | 2.70631009 |
143 | positive regulation of action potential (GO:0045760) | 2.70566926 |
144 | iron coordination entity transport (GO:1901678) | 2.70176259 |
145 | cholesterol homeostasis (GO:0042632) | 2.69823808 |
146 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.69510788 |
147 | carbohydrate derivative transport (GO:1901264) | 2.69415240 |
148 | regulation of systemic arterial blood pressure (GO:0003073) | 2.68824510 |
149 | positive regulation of actin filament depolymerization (GO:0030836) | 2.67076523 |
150 | response to epinephrine (GO:0071871) | 2.66390154 |
151 | negative regulation of JUN kinase activity (GO:0043508) | 2.65457151 |
152 | alcohol biosynthetic process (GO:0046165) | 2.65213568 |
153 | regulation of cholesterol metabolic process (GO:0090181) | 2.64826283 |
154 | metanephric nephron epithelium development (GO:0072243) | 2.64111744 |
155 | low-density lipoprotein particle remodeling (GO:0034374) | 2.63512348 |
156 | sterol homeostasis (GO:0055092) | 2.63005209 |
157 | neuron remodeling (GO:0016322) | 2.62586399 |
158 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.61633250 |
159 | glial cell development (GO:0021782) | 2.60913095 |
160 | heme transport (GO:0015886) | 2.59873818 |
161 | vitamin transport (GO:0051180) | 2.59516099 |
162 | negative regulation of axon extension (GO:0030517) | 2.58908494 |
163 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.58098691 |
164 | epoxygenase P450 pathway (GO:0019373) | 2.57249197 |
165 | positive regulation of glial cell differentiation (GO:0045687) | 2.56530132 |
166 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 2.56312375 |
167 | nerve growth factor signaling pathway (GO:0038180) | 2.55898915 |
168 | positive regulation of steroid metabolic process (GO:0045940) | 2.55370717 |
169 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.55247799 |
170 | regulation of plasminogen activation (GO:0010755) | 2.55060051 |
171 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.54971305 |
172 | peptide hormone processing (GO:0016486) | 2.54818228 |
173 | protein neddylation (GO:0045116) | 2.54799228 |
174 | cholesterol metabolic process (GO:0008203) | 2.54166727 |
175 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.53363987 |
176 | enteric nervous system development (GO:0048484) | 2.53259372 |
177 | metanephric epithelium development (GO:0072207) | 2.52827501 |
178 | glial cell differentiation (GO:0010001) | 2.52492352 |
179 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.52069914 |
180 | positive regulation of pseudopodium assembly (GO:0031274) | 2.51182375 |
181 | L-phenylalanine catabolic process (GO:0006559) | 2.50941005 |
182 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.50941005 |
183 | regulation of guanylate cyclase activity (GO:0031282) | 2.50788943 |
184 | regulation of cholesterol homeostasis (GO:2000188) | 2.50767466 |
185 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.50746495 |
186 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.49808036 |
187 | basic amino acid transport (GO:0015802) | 2.49323586 |
188 | phosphatidylserine metabolic process (GO:0006658) | 2.48020218 |
189 | axon ensheathment in central nervous system (GO:0032291) | 11.1268468 |
190 | central nervous system myelination (GO:0022010) | 11.1268468 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.62270772 |
2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.25699497 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.10348238 |
4 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.06391316 |
5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.90607217 |
6 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.77469764 |
7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.57022611 |
8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.41360854 |
9 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.25485066 |
10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.17096057 |
11 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.16954782 |
12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.16326667 |
13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.15184384 |
14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.14533347 |
15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.11990779 |
16 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.09431504 |
17 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.08850962 |
18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.05937570 |
19 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.05825456 |
20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.02142209 |
21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.99816872 |
22 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.96782427 |
23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.96441670 |
24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.95427945 |
25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.90700090 |
26 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.90670823 |
27 | VDR_22108803_ChIP-Seq_LS180_Human | 1.85867825 |
28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.85164048 |
29 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.84059856 |
30 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.83366410 |
31 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.81089720 |
32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.80680131 |
33 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.78552655 |
34 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.76721324 |
35 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.76721324 |
36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76515427 |
37 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.76280536 |
38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.75854017 |
39 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.75371965 |
40 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.74430642 |
41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.70685146 |
42 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.69765494 |
43 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.67471233 |
44 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.66691603 |
45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.63325388 |
46 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.63196985 |
47 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.62877366 |
48 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.61095651 |
49 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.58016889 |
50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.53484124 |
51 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.52235685 |
52 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.51976495 |
53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.49795543 |
54 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.48681248 |
55 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.47782825 |
56 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.46954972 |
57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45037857 |
58 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.44799691 |
59 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.44381210 |
60 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.39092516 |
61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38377531 |
62 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37293324 |
63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.36434417 |
64 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.36344032 |
65 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.35950689 |
66 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35874944 |
67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.35194928 |
68 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.34964094 |
69 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.33881170 |
70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.33241125 |
71 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.31682222 |
72 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.31500837 |
73 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.31457117 |
74 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.30431918 |
75 | KDM2B_26808549_Chip-Seq_K562_Human | 1.29388164 |
76 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28439997 |
77 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28072987 |
78 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.26148113 |
79 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.26110086 |
80 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.24675573 |
81 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.24083277 |
82 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23166175 |
83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23166175 |
84 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.23044403 |
85 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.20643559 |
86 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18653865 |
87 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18081429 |
88 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.17291344 |
89 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16869609 |
90 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16568598 |
91 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.15071481 |
92 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14994132 |
93 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14977078 |
94 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13716409 |
95 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11842999 |
96 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.11316971 |
97 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.10733965 |
98 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.10402586 |
99 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.10342885 |
100 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10058913 |
101 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09342973 |
102 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.08547029 |
103 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.08359806 |
104 | P300_19829295_ChIP-Seq_ESCs_Human | 1.07698953 |
105 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.07281484 |
106 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07161265 |
107 | P68_20966046_ChIP-Seq_HELA_Human | 1.06491835 |
108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06083456 |
109 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.06073330 |
110 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05161197 |
111 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04980862 |
112 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.04344543 |
113 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.03905157 |
114 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.03810460 |
115 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03152319 |
116 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.02638796 |
117 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00716335 |
118 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99993745 |
119 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.99917945 |
120 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99135919 |
121 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98999380 |
122 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97712023 |
123 | SA1_27219007_Chip-Seq_Bcells_Human | 0.97590666 |
124 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96936429 |
125 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96100903 |
126 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95920567 |
127 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.95520264 |
128 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95465553 |
129 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95189845 |
130 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.95174849 |
131 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.95132562 |
132 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.95074833 |
133 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.94332266 |
134 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93276997 |
135 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.93211468 |
136 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93142935 |
137 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92558913 |
138 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92495654 |
139 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92245136 |
140 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91685615 |
141 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91087027 |
142 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.90826429 |
143 | TCF4_23295773_ChIP-Seq_U87_Human | 0.89211878 |
144 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89191147 |
145 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.88983085 |
146 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.88802406 |
147 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.88730925 |
148 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.88127887 |
149 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87879436 |
150 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.87436165 |
151 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87286179 |
152 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.86668662 |
153 | TBL1_22424771_ChIP-Seq_293T_Human | 0.86448077 |
154 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86225502 |
155 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.85999950 |
156 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.85829830 |
157 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.85251722 |
158 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84987737 |
159 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.84962626 |
160 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84933958 |
161 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84929968 |
162 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.84680714 |
163 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.84680714 |
164 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83164160 |
165 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.82684723 |
166 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.82128236 |
167 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.81887984 |
168 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.80631948 |
169 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.80595845 |
170 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.80178531 |
171 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.79806782 |
172 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.79426568 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.30616946 |
2 | MP0005360_urolithiasis | 5.74170659 |
3 | * MP0000920_abnormal_myelination | 5.62003224 |
4 | MP0003950_abnormal_plasma_membrane | 3.47295387 |
5 | MP0003880_abnormal_central_pattern | 3.45548597 |
6 | MP0004270_analgesia | 3.30749847 |
7 | MP0003690_abnormal_glial_cell | 3.25829581 |
8 | MP0005084_abnormal_gallbladder_morpholo | 3.25548854 |
9 | MP0005083_abnormal_biliary_tract | 2.96965003 |
10 | MP0005365_abnormal_bile_salt | 2.87886032 |
11 | MP0003329_amyloid_beta_deposits | 2.86403928 |
12 | MP0004742_abnormal_vestibular_system | 2.72348203 |
13 | MP0003136_yellow_coat_color | 2.72184278 |
14 | MP0005085_abnormal_gallbladder_physiolo | 2.71050067 |
15 | MP0004885_abnormal_endolymph | 2.67924764 |
16 | MP0001529_abnormal_vocalization | 2.63373665 |
17 | MP0004019_abnormal_vitamin_homeostasis | 2.62681238 |
18 | MP0003634_abnormal_glial_cell | 2.50645633 |
19 | MP0005451_abnormal_body_composition | 2.42541431 |
20 | MP0001905_abnormal_dopamine_level | 2.42467168 |
21 | MP0002272_abnormal_nervous_system | 2.36328503 |
22 | MP0005332_abnormal_amino_acid | 2.34677064 |
23 | MP0001485_abnormal_pinna_reflex | 2.31273112 |
24 | MP0001486_abnormal_startle_reflex | 2.27562008 |
25 | MP0004043_abnormal_pH_regulation | 2.27144595 |
26 | MP0000462_abnormal_digestive_system | 2.25445796 |
27 | MP0003879_abnormal_hair_cell | 2.20374342 |
28 | MP0003183_abnormal_peptide_metabolism | 2.18701260 |
29 | MP0005171_absent_coat_pigmentation | 2.15767793 |
30 | MP0003806_abnormal_nucleotide_metabolis | 2.15180010 |
31 | MP0001666_abnormal_nutrient_absorption | 2.14459503 |
32 | MP0004142_abnormal_muscle_tone | 2.13805503 |
33 | MP0010329_abnormal_lipoprotein_level | 2.12898009 |
34 | MP0005409_darkened_coat_color | 2.07697383 |
35 | MP0010386_abnormal_urinary_bladder | 2.06467699 |
36 | MP0003632_abnormal_nervous_system | 2.01050928 |
37 | MP0010678_abnormal_skin_adnexa | 1.99431025 |
38 | MP0000778_abnormal_nervous_system | 1.98861374 |
39 | MP0002064_seizures | 1.92097573 |
40 | MP0003122_maternal_imprinting | 1.88492617 |
41 | MP0002138_abnormal_hepatobiliary_system | 1.84239479 |
42 | MP0004381_abnormal_hair_follicle | 1.83200819 |
43 | MP0002229_neurodegeneration | 1.83040562 |
44 | MP0000383_abnormal_hair_follicle | 1.77343372 |
45 | MP0003195_calcinosis | 1.77090033 |
46 | MP0005410_abnormal_fertilization | 1.76607301 |
47 | MP0003252_abnormal_bile_duct | 1.75715423 |
48 | MP0002089_abnormal_postnatal_growth/wei | 1.75169732 |
49 | MP0002928_abnormal_bile_duct | 1.75115560 |
50 | MP0005423_abnormal_somatic_nervous | 1.69139666 |
51 | MP0002734_abnormal_mechanical_nocicepti | 1.59631865 |
52 | MP0002822_catalepsy | 1.55269086 |
53 | MP0000604_amyloidosis | 1.50939026 |
54 | MP0001756_abnormal_urination | 1.50644265 |
55 | MP0009046_muscle_twitch | 1.48383467 |
56 | MP0004147_increased_porphyrin_level | 1.46740612 |
57 | MP0004134_abnormal_chest_morphology | 1.44966393 |
58 | MP0004133_heterotaxia | 1.44699991 |
59 | MP0002909_abnormal_adrenal_gland | 1.43946922 |
60 | MP0008875_abnormal_xenobiotic_pharmacok | 1.41407657 |
61 | MP0009780_abnormal_chondrocyte_physiolo | 1.40232191 |
62 | MP0003631_nervous_system_phenotype | 1.39449215 |
63 | MP0009745_abnormal_behavioral_response | 1.39123798 |
64 | MP0004859_abnormal_synaptic_plasticity | 1.38115191 |
65 | MP0000678_abnormal_parathyroid_gland | 1.38005044 |
66 | MP0003283_abnormal_digestive_organ | 1.35187273 |
67 | MP0009643_abnormal_urine_homeostasis | 1.31141858 |
68 | MP0000955_abnormal_spinal_cord | 1.30599769 |
69 | MP0003635_abnormal_synaptic_transmissio | 1.30482355 |
70 | MP0001661_extended_life_span | 1.27804724 |
71 | MP0005670_abnormal_white_adipose | 1.26157694 |
72 | MP0005551_abnormal_eye_electrophysiolog | 1.25984955 |
73 | MP0001963_abnormal_hearing_physiology | 1.25949851 |
74 | MP0002876_abnormal_thyroid_physiology | 1.25124297 |
75 | * MP0002882_abnormal_neuron_morphology | 1.22388511 |
76 | MP0000647_abnormal_sebaceous_gland | 1.19830403 |
77 | MP0000747_muscle_weakness | 1.18581685 |
78 | MP0005408_hypopigmentation | 1.12619959 |
79 | * MP0002066_abnormal_motor_capabilities/c | 1.11416643 |
80 | MP0008260_abnormal_autophagy | 1.11061122 |
81 | MP0001346_abnormal_lacrimal_gland | 1.10261249 |
82 | MP0001970_abnormal_pain_threshold | 1.10120988 |
83 | MP0001299_abnormal_eye_distance/ | 1.10066597 |
84 | MP0000639_abnormal_adrenal_gland | 1.09711191 |
85 | MP0005058_abnormal_lysosome_morphology | 1.09232438 |
86 | MP0001440_abnormal_grooming_behavior | 1.08857917 |
87 | MP0003633_abnormal_nervous_system | 1.08373302 |
88 | MP0002752_abnormal_somatic_nervous | 1.06381267 |
89 | MP0002067_abnormal_sensory_capabilities | 1.06087920 |
90 | MP0002572_abnormal_emotion/affect_behav | 1.05820947 |
91 | MP0001851_eye_inflammation | 1.01146643 |
92 | MP0000013_abnormal_adipose_tissue | 1.01099951 |
93 | MP0008569_lethality_at_weaning | 1.00686859 |
94 | MP0002733_abnormal_thermal_nociception | 0.98116194 |
95 | MP0009379_abnormal_foot_pigmentation | 0.97581998 |
96 | MP0005623_abnormal_meninges_morphology | 0.96661400 |
97 | MP0002254_reproductive_system_inflammat | 0.96602883 |
98 | MP0000467_abnormal_esophagus_morphology | 0.96513506 |
99 | MP0002063_abnormal_learning/memory/cond | 0.95212596 |
100 | MP0001944_abnormal_pancreas_morphology | 0.93915190 |
101 | MP0004924_abnormal_behavior | 0.93244799 |
102 | MP0005386_behavior/neurological_phenoty | 0.93244799 |
103 | MP0002557_abnormal_social/conspecific_i | 0.93212718 |
104 | MP0004858_abnormal_nervous_system | 0.92194348 |
105 | MP0000762_abnormal_tongue_morphology | 0.91877178 |
106 | MP0003938_abnormal_ear_development | 0.90189539 |
107 | MP0005195_abnormal_posterior_eye | 0.89767555 |
108 | MP0010030_abnormal_orbit_morphology | 0.88796640 |
109 | MP0002295_abnormal_pulmonary_circulatio | 0.88786991 |
110 | MP0005636_abnormal_mineral_homeostasis | 0.88549181 |
111 | MP0001502_abnormal_circadian_rhythm | 0.88266233 |
112 | MP0000566_synostosis | 0.87684077 |
113 | MP0004264_abnormal_extraembryonic_tissu | 0.87506595 |
114 | MP0003937_abnormal_limbs/digits/tail_de | 0.86142736 |
115 | MP0000538_abnormal_urinary_bladder | 0.84850842 |
116 | MP0008438_abnormal_cutaneous_collagen | 0.84118248 |
117 | MP0008872_abnormal_physiological_respon | 0.82856676 |
118 | MP0003123_paternal_imprinting | 0.81754773 |
119 | MP0001177_atelectasis | 0.81533694 |
120 | MP0001968_abnormal_touch/_nociception | 0.79190152 |
121 | MP0001764_abnormal_homeostasis | 0.78689028 |
122 | MP0000026_abnormal_inner_ear | 0.78429719 |
123 | MP0001765_abnormal_ion_homeostasis | 0.77768792 |
124 | MP0001664_abnormal_digestion | 0.77348389 |
125 | MP0005645_abnormal_hypothalamus_physiol | 0.75785120 |
126 | MP0002796_impaired_skin_barrier | 0.75241861 |
127 | MP0009840_abnormal_foam_cell | 0.75085552 |
128 | MP0004272_abnormal_basement_membrane | 0.74095731 |
129 | MP0003718_maternal_effect | 0.73858547 |
130 | MP0002249_abnormal_larynx_morphology | 0.73640157 |
131 | MP0003011_delayed_dark_adaptation | 0.73512654 |
132 | MP0000579_abnormal_nail_morphology | 0.73271222 |
133 | MP0004145_abnormal_muscle_electrophysio | 0.72411466 |
134 | MP0001986_abnormal_taste_sensitivity | 0.71463721 |
135 | MP0005220_abnormal_exocrine_pancreas | 0.70949567 |
136 | MP0005375_adipose_tissue_phenotype | 0.70758003 |
137 | MP0003119_abnormal_digestive_system | 0.70701258 |
138 | MP0006072_abnormal_retinal_apoptosis | 0.70398754 |
139 | MP0005379_endocrine/exocrine_gland_phen | 0.69743496 |
140 | MP0001984_abnormal_olfaction | 0.69590123 |
141 | MP0002090_abnormal_vision | 0.67881876 |
142 | MP0003953_abnormal_hormone_level | 0.67768931 |
143 | MP0005253_abnormal_eye_physiology | 0.66720375 |
144 | * MP0002152_abnormal_brain_morphology | 0.66094731 |
145 | MP0002136_abnormal_kidney_physiology | 0.65726368 |
146 | MP0000534_abnormal_ureter_morphology | 0.65636309 |
147 | MP0002184_abnormal_innervation | 0.64489786 |
148 | MP0004185_abnormal_adipocyte_glucose | 0.64211825 |
149 | MP0005448_abnormal_energy_balance | 0.63908821 |
150 | MP0002736_abnormal_nociception_after | 0.63822044 |
151 | MP0001340_abnormal_eyelid_morphology | 0.63810885 |
152 | MP0001348_abnormal_lacrimal_gland | 0.62918032 |
153 | MP0000003_abnormal_adipose_tissue | 0.59606138 |
154 | MP0002133_abnormal_respiratory_system | 0.58995382 |
155 | MP0005388_respiratory_system_phenotype | 0.58995382 |
156 | MP0002118_abnormal_lipid_homeostasis | 0.58684899 |
157 | MP0005381_digestive/alimentary_phenotyp | 0.56573517 |
158 | MP0009384_cardiac_valve_regurgitation | 0.55823028 |
159 | MP0002735_abnormal_chemical_nociception | 0.55549104 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.60298185 |
2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.60298185 |
3 | Neurofibrillary tangles (HP:0002185) | 6.10760875 |
4 | Parakeratosis (HP:0001036) | 5.19417740 |
5 | Sensory axonal neuropathy (HP:0003390) | 5.06944685 |
6 | Abnormality of the corticospinal tract (HP:0002492) | 4.90281846 |
7 | Peripheral hypomyelination (HP:0007182) | 4.64840023 |
8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.60760323 |
9 | Cerebral inclusion bodies (HP:0100314) | 4.37252656 |
10 | Termporal pattern (HP:0011008) | 4.08093200 |
11 | Insidious onset (HP:0003587) | 4.08093200 |
12 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.06202776 |
13 | Focal segmental glomerulosclerosis (HP:0000097) | 4.06151732 |
14 | Onion bulb formation (HP:0003383) | 4.00448650 |
15 | Hydroxyprolinuria (HP:0003080) | 3.81236174 |
16 | Abnormality of proline metabolism (HP:0010907) | 3.81236174 |
17 | Hypobetalipoproteinemia (HP:0003563) | 3.74020429 |
18 | Gout (HP:0001997) | 3.73056197 |
19 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.68130209 |
20 | Xanthomatosis (HP:0000991) | 3.65024786 |
21 | Cerebral hypomyelination (HP:0006808) | 3.55101789 |
22 | Supranuclear gaze palsy (HP:0000605) | 3.40972278 |
23 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.40917946 |
24 | Spastic gait (HP:0002064) | 3.39759431 |
25 | Increased serum pyruvate (HP:0003542) | 3.39638756 |
26 | Abnormality of glycolysis (HP:0004366) | 3.39638756 |
27 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.27475149 |
28 | Hyperglycinuria (HP:0003108) | 3.26423408 |
29 | Late onset (HP:0003584) | 3.23439757 |
30 | Intention tremor (HP:0002080) | 3.22657704 |
31 | Metabolic alkalosis (HP:0200114) | 3.20609980 |
32 | Glomerulosclerosis (HP:0000096) | 3.19227460 |
33 | Increased circulating renin level (HP:0000848) | 3.18812618 |
34 | Distal upper limb amyotrophy (HP:0007149) | 3.18124573 |
35 | Upper limb amyotrophy (HP:0009129) | 3.18124573 |
36 | Potter facies (HP:0002009) | 3.17759832 |
37 | Facial shape deformation (HP:0011334) | 3.17759832 |
38 | Abnormality of glycine metabolism (HP:0010895) | 3.15145534 |
39 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.15145534 |
40 | Abnormal auditory evoked potentials (HP:0006958) | 3.13111618 |
41 | Hand muscle atrophy (HP:0009130) | 3.07629144 |
42 | Hypomagnesemia (HP:0002917) | 3.02452590 |
43 | Leukodystrophy (HP:0002415) | 2.97697291 |
44 | Alacrima (HP:0000522) | 2.93488146 |
45 | Akinesia (HP:0002304) | 2.91266878 |
46 | Dysmetria (HP:0001310) | 2.88547187 |
47 | Hypokalemic alkalosis (HP:0001949) | 2.79905318 |
48 | Abnormal pancreas size (HP:0012094) | 2.78903506 |
49 | Hypoplastic pelvis (HP:0008839) | 2.78439558 |
50 | Hyperglycinemia (HP:0002154) | 2.75788121 |
51 | Scanning speech (HP:0002168) | 2.64545852 |
52 | Premature skin wrinkling (HP:0100678) | 2.64432238 |
53 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.62065384 |
54 | Retinal dysplasia (HP:0007973) | 2.61585655 |
55 | Slow saccadic eye movements (HP:0000514) | 2.55632533 |
56 | Ankle clonus (HP:0011448) | 2.55304503 |
57 | Prolonged partial thromboplastin time (HP:0003645) | 2.55143603 |
58 | Spastic paraparesis (HP:0002313) | 2.54267837 |
59 | Stridor (HP:0010307) | 2.53213740 |
60 | Cerebral hemorrhage (HP:0001342) | 2.50635515 |
61 | Hypercholesterolemia (HP:0003124) | 2.50493340 |
62 | Hyperuricemia (HP:0002149) | 2.50080272 |
63 | Increased purine levels (HP:0004368) | 2.50080272 |
64 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.44370674 |
65 | Autoamputation (HP:0001218) | 2.44106569 |
66 | Anteriorly placed anus (HP:0001545) | 2.43473014 |
67 | Malnutrition (HP:0004395) | 2.41515498 |
68 | Myokymia (HP:0002411) | 2.40050078 |
69 | Abnormality of magnesium homeostasis (HP:0004921) | 2.38258715 |
70 | Abnormality of purine metabolism (HP:0004352) | 2.36225487 |
71 | Thickened helices (HP:0000391) | 2.35713654 |
72 | Bicornuate uterus (HP:0000813) | 2.35628335 |
73 | Glycosuria (HP:0003076) | 2.34996620 |
74 | Abnormality of urine glucose concentration (HP:0011016) | 2.34996620 |
75 | Hypolipoproteinemia (HP:0010981) | 2.34221529 |
76 | Hemorrhage of the eye (HP:0011885) | 2.32468291 |
77 | Absent septum pellucidum (HP:0001331) | 2.30595279 |
78 | Partial agenesis of the corpus callosum (HP:0001338) | 2.30057606 |
79 | Clumsiness (HP:0002312) | 2.26294951 |
80 | Nephrolithiasis (HP:0000787) | 2.24191428 |
81 | Decreased lacrimation (HP:0000633) | 2.23776635 |
82 | Proximal tubulopathy (HP:0000114) | 2.22268419 |
83 | Foot dorsiflexor weakness (HP:0009027) | 2.19659143 |
84 | Hypercalciuria (HP:0002150) | 2.19276376 |
85 | Action tremor (HP:0002345) | 2.18353954 |
86 | Ulnar claw (HP:0001178) | 2.17315642 |
87 | Pheochromocytoma (HP:0002666) | 2.13905004 |
88 | Vaginal fistula (HP:0004320) | 2.13762621 |
89 | Pigmentary retinal degeneration (HP:0001146) | 2.12680471 |
90 | Hepatosplenomegaly (HP:0001433) | 2.11916451 |
91 | Ulnar bowing (HP:0003031) | 2.11693429 |
92 | CNS hypomyelination (HP:0003429) | 2.10924629 |
93 | Morphological abnormality of the inner ear (HP:0011390) | 2.10350304 |
94 | Cupped ear (HP:0000378) | 2.09852110 |
95 | Hypoplasia of the uterus (HP:0000013) | 2.09312475 |
96 | Steppage gait (HP:0003376) | 2.08714562 |
97 | Spastic tetraparesis (HP:0001285) | 2.07859998 |
98 | Abnormality of the vitreous humor (HP:0004327) | 2.03441794 |
99 | Hyperlipoproteinemia (HP:0010980) | 2.02484965 |
100 | Hammertoe (HP:0001765) | 2.01800190 |
101 | Esophageal atresia (HP:0002032) | 2.01211953 |
102 | Confusion (HP:0001289) | 2.00896497 |
103 | Adrenal hypoplasia (HP:0000835) | 2.00058103 |
104 | Deep venous thrombosis (HP:0002625) | 1.99938028 |
105 | Decreased motor nerve conduction velocity (HP:0003431) | 1.99703683 |
106 | Renal Fanconi syndrome (HP:0001994) | 1.98199528 |
107 | Infantile muscular hypotonia (HP:0008947) | 1.97977796 |
108 | Delayed CNS myelination (HP:0002188) | 1.97571246 |
109 | Abnormality of the foot musculature (HP:0001436) | 1.95959449 |
110 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.95693949 |
111 | Vascular calcification (HP:0004934) | 1.94141834 |
112 | Split foot (HP:0001839) | 1.94092341 |
113 | Patchy hypopigmentation of hair (HP:0011365) | 1.91564650 |
114 | Methylmalonic acidemia (HP:0002912) | 1.91265074 |
115 | Abnormality of nucleobase metabolism (HP:0010932) | 1.91258714 |
116 | Abnormal urine phosphate concentration (HP:0012599) | 1.90788229 |
117 | Humeroradial synostosis (HP:0003041) | 1.89606412 |
118 | Synostosis involving the elbow (HP:0003938) | 1.89606412 |
119 | Lower limb muscle weakness (HP:0007340) | 1.89284054 |
120 | Abnormality of the septum pellucidum (HP:0007375) | 1.89271116 |
121 | Axonal loss (HP:0003447) | 1.89053511 |
122 | Peripheral demyelination (HP:0011096) | 1.88982178 |
123 | Joint hemorrhage (HP:0005261) | 1.88526362 |
124 | Anomalous pulmonary venous return (HP:0010772) | 1.87905567 |
125 | Abnormality of vitamin metabolism (HP:0100508) | 1.86963939 |
126 | Intrahepatic cholestasis (HP:0001406) | 1.86275193 |
127 | Mesangial abnormality (HP:0001966) | 1.86076893 |
128 | Acute necrotizing encephalopathy (HP:0006965) | 1.85982468 |
129 | White forelock (HP:0002211) | 1.85762492 |
130 | Ileus (HP:0002595) | 1.85711906 |
131 | Fat malabsorption (HP:0002630) | 1.85221548 |
132 | Abnormal urine output (HP:0012590) | 1.84853384 |
133 | Coronal craniosynostosis (HP:0004440) | 1.84528914 |
134 | Erythroderma (HP:0001019) | 1.84089563 |
135 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.83167796 |
136 | Neuroendocrine neoplasm (HP:0100634) | 1.82487772 |
137 | Hypophosphatemic rickets (HP:0004912) | 1.82363920 |
138 | Hypoplasia of the iris (HP:0007676) | 1.82323252 |
139 | Athetosis (HP:0002305) | 1.81673231 |
140 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.80677426 |
141 | J-shaped sella turcica (HP:0002680) | 1.80559238 |
142 | Abnormality of renal excretion (HP:0011036) | 1.80448362 |
143 | Hypothermia (HP:0002045) | 1.77983296 |
144 | Acute encephalopathy (HP:0006846) | 1.77711710 |
145 | Alkalosis (HP:0001948) | 1.77487512 |
146 | Renal salt wasting (HP:0000127) | 1.77413660 |
147 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.77381990 |
148 | Megalencephaly (HP:0001355) | 1.77119375 |
149 | Barrel-shaped chest (HP:0001552) | 1.76246142 |
150 | Distal sensory impairment (HP:0002936) | 1.75469018 |
151 | Bronchomalacia (HP:0002780) | 1.75413515 |
152 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.75013675 |
153 | Clonus (HP:0002169) | 1.74521325 |
154 | Muscle fiber splitting (HP:0003555) | 1.72183335 |
155 | Urinary incontinence (HP:0000020) | 1.71723588 |
156 | Nuclear cataract (HP:0100018) | 1.71524559 |
157 | Widely patent fontanelles and sutures (HP:0004492) | 1.70217431 |
158 | Generalized myoclonic seizures (HP:0002123) | 1.69885659 |
159 | Gowers sign (HP:0003391) | 1.68937742 |
160 | Choanal stenosis (HP:0000452) | 1.68635190 |
161 | Abnormality of the vocal cords (HP:0008777) | 1.68568832 |
162 | Hyperphosphaturia (HP:0003109) | 1.68275466 |
163 | Hypophosphatemia (HP:0002148) | 1.68127733 |
164 | 3-Methylglutaconic aciduria (HP:0003535) | 1.67874315 |
165 | Hepatoblastoma (HP:0002884) | 1.67695884 |
166 | Paraparesis (HP:0002385) | 1.66571881 |
167 | Partial duplication of thumb phalanx (HP:0009944) | 1.65879938 |
168 | Sleep apnea (HP:0010535) | 1.65047301 |
169 | Abnormality of renin-angiotensin system (HP:0000847) | 1.64147881 |
170 | Abnormality of the Achilles tendon (HP:0005109) | 1.63916930 |
171 | Bowed forearm bones (HP:0003956) | 1.63278017 |
172 | Bowing of the arm (HP:0006488) | 1.63278017 |
173 | Turricephaly (HP:0000262) | 1.62878753 |
174 | Diaphragmatic weakness (HP:0009113) | 1.62621895 |
175 | Enlarged kidneys (HP:0000105) | 1.62290589 |
176 | Abnormality of carpal bone ossification (HP:0006257) | 1.62098909 |
177 | Rickets (HP:0002748) | 1.60369780 |
178 | Growth hormone excess (HP:0000845) | 1.59296619 |
179 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.58993965 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 6.44536171 |
2 | OXSR1 | 4.77880561 |
3 | EPHB1 | 3.90618096 |
4 | WNK4 | 3.32603450 |
5 | MST1R | 3.19655048 |
6 | BCR | 2.83244797 |
7 | EPHA2 | 2.67923342 |
8 | PBK | 2.64350051 |
9 | MAPKAPK5 | 2.58398100 |
10 | MET | 2.55113054 |
11 | FGFR4 | 2.49218826 |
12 | LMTK2 | 2.44481528 |
13 | DAPK2 | 2.43720089 |
14 | RIPK1 | 2.43316064 |
15 | PKN1 | 2.39270022 |
16 | CDK19 | 2.31222483 |
17 | TNIK | 2.17686568 |
18 | WNK1 | 2.06241300 |
19 | NTRK3 | 1.97757268 |
20 | LIMK1 | 1.91890737 |
21 | PRPF4B | 1.90361104 |
22 | UHMK1 | 1.87765742 |
23 | MST4 | 1.86116068 |
24 | ICK | 1.78326210 |
25 | FGFR2 | 1.74909880 |
26 | CSNK1G3 | 1.68765948 |
27 | MAP3K10 | 1.60940995 |
28 | CSNK1A1L | 1.58731434 |
29 | NEK6 | 1.54108588 |
30 | DYRK1B | 1.52165342 |
31 | NTRK1 | 1.50655376 |
32 | CLK1 | 1.47687428 |
33 | TESK2 | 1.45654477 |
34 | PNCK | 1.44442338 |
35 | FGR | 1.42845562 |
36 | ROCK2 | 1.39910388 |
37 | CAMK2B | 1.39863976 |
38 | ERN1 | 1.31185644 |
39 | EPHB2 | 1.29620276 |
40 | CSNK1G1 | 1.29397780 |
41 | ACVR1B | 1.29237849 |
42 | PTK2 | 1.24818250 |
43 | CSNK1G2 | 1.22233946 |
44 | PRKG2 | 1.22200996 |
45 | SGK223 | 1.20326639 |
46 | SGK494 | 1.20326639 |
47 | CAMK2D | 1.17805346 |
48 | MAPK15 | 1.15502852 |
49 | DAPK3 | 1.15278003 |
50 | MAP4K2 | 1.14794656 |
51 | PRKD3 | 1.14662935 |
52 | PRKCG | 1.10924957 |
53 | MAPKAPK3 | 1.10695901 |
54 | CASK | 1.09019237 |
55 | PAK6 | 1.02755977 |
56 | TYRO3 | 1.02062670 |
57 | PINK1 | 1.01382162 |
58 | MAP3K4 | 0.99094623 |
59 | SIK1 | 0.97548194 |
60 | EPHA4 | 0.97049628 |
61 | ERBB4 | 0.95856350 |
62 | PRKCI | 0.93414697 |
63 | PRKCZ | 0.90980374 |
64 | IRAK2 | 0.90818719 |
65 | CAMK2G | 0.89067306 |
66 | DYRK2 | 0.88243574 |
67 | WNK3 | 0.85129264 |
68 | PAK3 | 0.84881562 |
69 | PRKCQ | 0.84814706 |
70 | BRAF | 0.80935591 |
71 | CDK14 | 0.78169177 |
72 | MAP2K2 | 0.76231130 |
73 | CAMK2A | 0.76187878 |
74 | MARK1 | 0.76059201 |
75 | FGFR1 | 0.75756599 |
76 | MARK2 | 0.75465288 |
77 | PLK2 | 0.73555839 |
78 | CDK5 | 0.73239937 |
79 | ERBB2 | 0.72208104 |
80 | MINK1 | 0.71661404 |
81 | MAP3K9 | 0.67602920 |
82 | PRKD1 | 0.66334000 |
83 | DAPK1 | 0.66241600 |
84 | CDK15 | 0.64682828 |
85 | IRAK1 | 0.64249118 |
86 | SIK2 | 0.63299667 |
87 | TTN | 0.62541367 |
88 | MAP3K2 | 0.61356707 |
89 | MAP2K6 | 0.60275491 |
90 | PRKCE | 0.60023021 |
91 | MAPK11 | 0.59835416 |
92 | CDK18 | 0.58862561 |
93 | CDK11A | 0.58812906 |
94 | ABL2 | 0.58121927 |
95 | EEF2K | 0.57157149 |
96 | PDK2 | 0.55999624 |
97 | PHKG1 | 0.55543298 |
98 | PHKG2 | 0.55543298 |
99 | BRSK1 | 0.55327503 |
100 | PDPK1 | 0.55212930 |
101 | MAP2K7 | 0.55068241 |
102 | FYN | 0.54810673 |
103 | RPS6KA5 | 0.53775976 |
104 | FGFR3 | 0.52642800 |
105 | PRKAA1 | 0.52045284 |
106 | GRK5 | 0.49342249 |
107 | ARAF | 0.48481377 |
108 | AKT2 | 0.47456925 |
109 | GSK3A | 0.46641425 |
110 | CSNK1D | 0.45599966 |
111 | SGK1 | 0.45414975 |
112 | PDGFRA | 0.44782255 |
113 | PRKACG | 0.43810386 |
114 | KSR2 | 0.43126368 |
115 | BMPR1B | 0.43011548 |
116 | FES | 0.42538521 |
117 | CSNK1A1 | 0.42297399 |
118 | PRKG1 | 0.42120277 |
119 | PRKCA | 0.41506354 |
120 | CAMKK1 | 0.40306976 |
121 | PAK4 | 0.40065801 |
122 | MUSK | 0.39616069 |
123 | ILK | 0.38023539 |
124 | PRKAA2 | 0.37960854 |
125 | STK16 | 0.37908876 |
126 | PRKACB | 0.37577578 |
127 | DMPK | 0.37448931 |
128 | PDGFRB | 0.37410656 |
129 | RPS6KA2 | 0.36688403 |
130 | ADRBK2 | 0.36321481 |
131 | MKNK1 | 0.35736684 |
132 | PAK1 | 0.35088181 |
133 | STK11 | 0.34764173 |
134 | GRK7 | 0.33589643 |
135 | NME1 | 0.32778090 |
136 | MAPK13 | 0.31491725 |
137 | ITK | 0.30804394 |
138 | CAMK1G | 0.30168458 |
139 | PRKCH | 0.29724752 |
140 | HIPK2 | 0.29632157 |
141 | PRKACA | 0.29248703 |
142 | BMX | 0.29182097 |
143 | GRK1 | 0.28000987 |
144 | INSR | 0.27394598 |
145 | ROCK1 | 0.26181017 |
146 | TRPM7 | 0.26137344 |
147 | CSK | 0.25310260 |
148 | PTK2B | 0.22847109 |
149 | NTRK2 | 0.22070961 |
150 | DDR2 | 0.21975260 |
151 | MAPK7 | 0.21568653 |
152 | OBSCN | 0.21139417 |
153 | PDK1 | 0.20130758 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.90595366 |
2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 5.12307019 |
3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.71620512 |
4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 4.12651746 |
5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.91742525 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.88920574 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.75196820 |
8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.69929055 |
9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.64475714 |
10 | * Ether lipid metabolism_Homo sapiens_hsa00565 | 2.63186282 |
11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.56439604 |
12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.56073886 |
13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.32687123 |
14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.20669042 |
15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.13167900 |
16 | Protein export_Homo sapiens_hsa03060 | 2.07720995 |
17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02051067 |
18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.86786194 |
19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.82330734 |
20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.81732851 |
21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78402759 |
22 | Bile secretion_Homo sapiens_hsa04976 | 1.75042659 |
23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.72369357 |
24 | Galactose metabolism_Homo sapiens_hsa00052 | 1.72027626 |
25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.68818415 |
26 | Sulfur relay system_Homo sapiens_hsa04122 | 1.65795762 |
27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.65431526 |
28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.61386634 |
29 | Axon guidance_Homo sapiens_hsa04360 | 1.53138134 |
30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.51143591 |
31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47979898 |
32 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.45396663 |
33 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.44776461 |
34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.42530239 |
35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.37859634 |
36 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.32363710 |
37 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.26300220 |
38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22439204 |
39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18395882 |
40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.16929578 |
41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.15222362 |
42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.08205345 |
43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.05752564 |
44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.05151441 |
45 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.04929531 |
46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.04187968 |
47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99825333 |
48 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.99256106 |
49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96660557 |
50 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.95325214 |
51 | Insulin secretion_Homo sapiens_hsa04911 | 0.92015050 |
52 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91563847 |
53 | Tight junction_Homo sapiens_hsa04530 | 0.91223327 |
54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90841767 |
55 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.90638102 |
56 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.87529876 |
57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85739234 |
58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85531767 |
59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85524593 |
60 | GABAergic synapse_Homo sapiens_hsa04727 | 0.85235065 |
61 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.84474147 |
62 | Long-term depression_Homo sapiens_hsa04730 | 0.83420089 |
63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83334280 |
64 | Mineral absorption_Homo sapiens_hsa04978 | 0.79492991 |
65 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.78703751 |
66 | Peroxisome_Homo sapiens_hsa04146 | 0.78081656 |
67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76710880 |
68 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73874008 |
69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73725008 |
70 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.72636548 |
71 | Huntingtons disease_Homo sapiens_hsa05016 | 0.72415242 |
72 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.72279843 |
73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71308952 |
74 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70924101 |
75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.70721522 |
76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68906844 |
77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65962936 |
78 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.63952686 |
79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.63676792 |
80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.62693582 |
81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61051938 |
82 | Nicotine addiction_Homo sapiens_hsa05033 | 0.59697281 |
83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58796384 |
84 | Morphine addiction_Homo sapiens_hsa05032 | 0.57933935 |
85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57925266 |
86 | Lysosome_Homo sapiens_hsa04142 | 0.56249887 |
87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55898239 |
88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55726679 |
89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54360656 |
90 | Endocytosis_Homo sapiens_hsa04144 | 0.53511822 |
91 | Cocaine addiction_Homo sapiens_hsa05030 | 0.53355396 |
92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52984029 |
93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51772274 |
94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51679707 |
95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51587680 |
96 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.51040776 |
97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50333317 |
98 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.49339916 |
99 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49280728 |
100 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49081896 |
101 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.48991979 |
102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48481586 |
103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48360386 |
104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.46942843 |
105 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.45414059 |
106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44503296 |
107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39783890 |
108 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.39768621 |
109 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.39578104 |
110 | Circadian entrainment_Homo sapiens_hsa04713 | 0.38231577 |
111 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38130146 |
112 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38113258 |
113 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37630778 |
114 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.37608623 |
115 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.37563890 |
116 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37241892 |
117 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.37200225 |
118 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.37090551 |
119 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.36928061 |
120 | Salivary secretion_Homo sapiens_hsa04970 | 0.36260145 |
121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35943464 |
122 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35329254 |
123 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34529898 |
124 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32340784 |
125 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.32175747 |
126 | Phototransduction_Homo sapiens_hsa04744 | 0.31357877 |
127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30683465 |
128 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.29664953 |
129 | Phagosome_Homo sapiens_hsa04145 | 0.29449190 |
130 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.27841970 |
131 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27630825 |
132 | ABC transporters_Homo sapiens_hsa02010 | 0.27613100 |
133 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.27067916 |
134 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21125804 |
135 | Renin secretion_Homo sapiens_hsa04924 | 0.20983968 |
136 | Prion diseases_Homo sapiens_hsa05020 | 0.20180426 |
137 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.19780598 |
138 | Gap junction_Homo sapiens_hsa04540 | 0.19735468 |
139 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.19550030 |
140 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.19468684 |